IQV
IQVIA Holdings Inc.
Diagnostics & Research · Healthcare · United States
275.06
close · 2026-10-29
value
75
cheaper than peers75
quality
38
stronger fundamentals38
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| forward P/E | 19.31× | 88 |
| price to sales | 2.63× | 69 |
| EV to EBITDA | 19.47× | 68 |
| price to book | 6.81× | 47 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 22.8% | 81 |
| operating margin | 13.0% | 62 |
| revenue growth | 8.7% | 34 |
| debt to equity | 258.0% | 9 |
4 of 4 measures available
Facts
| market cap | $45B |
| free cash flow | $2.15B |
| employees | 94,000 |
| first trade | 2013-05-09 |
| next earnings | 2026-10-27 |
| fundamentals updated | 2026-10-27 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 7.84 | 7.49 | 7.29 | 5.72 |
| free cash flow | $2.05B | $2.11B | $1.50B | $1.59B |
| net income | $1.36B | $1.37B | $1.36B | $1.09B |
| revenue | $16.31B | $15.40B | $14.98B | $14.41B |
| unusual items | -$111.0M | -$67.0M | -$90.0M | -$28.0M |